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Abstract
Background: Although deficits of attentional set-shifting have been reported in individuals with attention deficit/
hyperactivity disorder (ADHD), it is rarely examined in animal models.
Methods: This study compared spontaneously hypertensive rats (SHRs; a genetic animal model of ADHD) and
Wistar-Kyoto (WKY) and Sprague-Dawley (SD) rats (normoactive control strains), on attentional set-shifting task
(ASST) performance. Furthermore, the dose-effects of methylphenidate (MPH) on attentional set-shifting of SHR
were investigated. In experiment 1, ASST procedures were conducted in SHR, WKY and SD rats of 8 each at the
age of 5 weeks. Mean latencies at the initial phase, error types and numbers, and trials to criteria at each stage
were recorded. In experiment 2, 24 SHR rats were randomly assigned to 3 groups of 8 each– MPH-L (lower dose),
MPH-H (higher dose), and SHR-vehicle groups. From 3 weeks, they were administered 2.5 mg/kg or 5 mg/kg MPH
or saline respectively for 14 consecutive days. All rats were tested in the ASST at the age of 5 weeks.
Results: The SHRs generally exhibited poorer performance on ASST than the control WKY and SD rats. Significant
strain effects on mean latency [F (2, 21) = 639.636, p < 0.001] and trials to criterion [F (2, 21) = 114.118, p < 0.001]
were observed. The SHRs were found to have more perseverative and regressive errors than the control strains (p
< 0.001). After MPH treatment, the two MPH treated groups exhibited significantly longer latency and fewer trials
to reach criterion than the SHR-vehicle group and the MPH-L group exhibited fewer trials to reach criterion in
more stages compared with the MPH-H group. Significant main effects of treatment [F (2, 21) = 52.174, p < 0.001]
and error subtype [F (2, 42) = 221.635, p < 0.01] were found.
Conclusions: The SHR may be impaired in discrimination learning, reversal learning and attentional set-shifting.
Our study provides evidence that MPH may improve the SHR’s performance on attentional set-shifting and lower
dose is more effective than higher dose.
Keywords: Attentional set-shifting, Attention deficit/hyperactivity disorder, Spontaneous hypertensive rat,
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Background
Attention deficit/hyperactivity disorder (ADHD), which
is characterized by developmentally inappropriate symp-
toms of inattention, impulsivity and hyperactivity, is
among the most common neuropsychiatric disorders in
children. The symptoms of ADHD manifest as distract-
ibility, difficulty in sustaining attention, and a failure to
appropriately control motor responses. Some have sug-
gested that all of these symptoms can be attributed to a
primary deficit of cognition in ADHD sufferers, particu-
larly impairment of executive functions [1]. Previous
studies have reported deficits of attentional set-shifting-
a type of executive functions-in individuals with ADHD
[2-4]. Assessing set-shifting in an animal model can help
elucidate the neural mechanisms of ADHD. The sponta-
neously hypertensive rat (SHR) has been evaluated
extensively as an animal model of ADHD, including its
neurochemical, genetic, and behavioral characteristics
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dies addressed the nature of set-shifting ability in SHR,
which generated conflicting results. Kantak et al. [6] in
2008 found that SHRs exhibited poorer set-shifting
compared to inbred Wistar-Kyoto (WKY). Chess AC et
al. [7] reported that the SHRs were faster than Wistar
rats in shifting to the opposite discrimination when
there was 1 or 2 days between the initial discrimination
and the shift but equivalent in shifting when the shift
between discriminations occurred immediately after a
criterion had been met in the first discrimination, which
m a yb ed u et oaf a i l u r eo fS H R st os t o r eo rr e t r i e v ea n
initial discrimination and/or latent inhibition over a
delay. The divergence of these 2 studies may due to dif-
ferent strains or experimental conditions. Given the
importance of set-shifting for understanding ADHD,
more studies are needed.
Attentional set-shifting is a form of executive function
that represents behavioral flexibility. It requires attend-
ing to relevant stimuli while ignoring irrelevant stimuli
and subsequently shifting the allocation of attention,
either within “dimensions” or between “dimensions” [8].
Deficits of set-shifting in individuals with ADHD have
been investigated with some different neuropsychologi-
cal tests, and the results may depend on which test is
administered. For example, in the attentional set-shifting
paradigm from the Attentional Battery of the Cambridge
Neuropsychological Test Automated Battery (CANTAB),
participants are required to discriminate between two
stimuli that differ in color and shape. Children and
adults with ADHD sometimes make more errors in a
set-shifting [9,10] and sometimes do not [11]. On the
other hand, the Trail Making Test (TMT), Part B from
the Halstead-Reitan battery generally takes longer to
complete (an indication of slower set-shifting) [12,13].
The limitations of these studies may also include varia-
bility in diagnosis, sample size and demographics.
Recently, the attentional set-shifting task (ASST), a simi-
lar procedure to commonly used attentional set-shifting
testing in humans with ADHD named the Wisconsin
Card Sorting Task (WCST) [14], was developed for rats
[8] and mice [15] model studies. In ASST, animals are
trained in serial discrimination learning stages to acquire
a rule and form an attentional set of a stimulus dimen-
sion. After that they will be required to shift attention
from this dimension to another previously irrelevant sti-
mulus dimension. This ability of shifting is tested as
cognitive flexibility (extradimensional shift, ED shift).
Meanwhile, other prefrontal cortical dependent cognitive
functions including working memory (reversal learning),
procedural memory (discrimination learning) can also
be measured separately. Assessing attentional set-shift-
i n gi na na n i m a lm o d e lo fA D H Dc a nh e l pa d d r e s s
some of the limitations of human study and elucidate its
neural mechanisms.
Methylphenidate (MPH) is one of the most commonly
used psycho-stimulants for the treatment of ADHD,
which has been found to improve spatial working mem-
ory, response inhibition, and other cognitive functions
in children with ADHD [16,17] and corresponding beha-
vior in animal models of ADHD [18]. However, neurop-
sychological tests of therapeutic effects of MPH on
attentional set-shifting in ADHD have yielded inconsis-
tent results (Table 1). The discrepancy of results may
come from different treatment regime, different age or
sex proportions of participants or lack of appropriate
controls. Some studies indicate that MPH produces an
inverted U dose response curve on cognitive perfor-
mance [19]. At lower dose (lower than 5.0 mg/kg for
rats), MPH could reduce movement, impulsivity and
increase cognitive function. For example, some research
show that lower dose of MPH could improve the perfor-
mance in delayed alternation task, sustained attention
task [20,21] and spatial learning and memory task [22]
in rats of ADHD models. In contrast, higher dose of
MPH (no less than 5.0 mg/kg for rats) may impair cog-
nition, elicit increase in locomotor activity [23], as well
as produce side effects like agitation, hallucinations, psy-
chosis, lethargy, seizures, tachycardia, dysrhythmia,
hypertension, and hyperthermia in humans of corre-
sponding dosage [24]. Given the discrepancy of results,
more studies are needed to identify the effects of MPH
on attentional set-shifting in ADHD.
This study aimed to assess the ability of attentional
set-shifting in SHRs (genetic animal model of ADHD)
compared with WKY and Sprague-Dawley (SD) rats
(normoactive control strains) by ASST, which applied us
a tool for further investigation of the neurobiological
and physiological mechanism underlying ADHD.
Furthermore, in Experiment 2 dose effects of MPH on
acquiring, maintaining and shifting attentional set of the
SHRs were investigated in order to delineate the effects
of MPH on attentional set-shifting deficits in ADHD
and enhance the understanding of the effects of drug
treatment on ADHD.
Methods
Subjects
In experiment 1, male rats of the SHR (n = 8), WKY (n
= 8) and SD (n = 8) strains were obtained at 3 weeks of
age from the Laboratory Animal Co., Lake Hayes Divi-
sion (Shanghai, China). Rats were housed individually in
plastic cages, in a 12 hr light/dark cycle (lights on from
06:00 to 18:00). Food and water were provided ad libi-
tum and the temperature was maintained at 21-23°C.
Prior to training on the set-shifting task, weights were
Cao et al. Behavioral and Brain Functions 2012, 8:10
http://www.behavioralandbrainfunctions.com/content/8/1/10
Page 2 of 10obtained and rats were then food deprived to 85% of the
free-feeding standard weight. In experiment 2, 24 SHRs
were randomly assigned to 3 groups of 8 each: MPH-L
(lower dose of MPH), MPH-H (higher dose of MPH)
and SHR-vehicle (saline) groups. Rats in the MPH-L
group were treated daily with MPH by dose of 2.5 mg/
kg [6], in the MPH-H treated with 5 mg/kg [6] MPH,
while animals in the SHR-vehicle were treated daily with
vehicle (saline). MPH (Ritalin
®)w a so b t a i n e df r o mQ i l u
Hospital of Shandong University and was dissolved in
saline. Peritoneal injection was conducted at 8 am daily
at the age of 3 weeks for 14 consecutive days. Rats were
tested in the ASST at the age of 5 weeks. All animal
procedures were conducted in strict compliance with
Protocols for Animal Use for Research and Education
approved by Medicine Animal Review Committee of
Shandong University.
Apparatus
The attentional set-shifting apparatus and procedures
were modifications of those previously described by Bir-
rell and Brown [8]. Rats were trained to retrieve food
reward by digging in small cups [29]. The test apparatus
was an adapted plastic cage (45 × 30 × 15 cm) with a
transparent plexiglass lid. Two equal-sized choice com-
partments (L and R, 15 × 15 cm) at one end of the appa-
ratus could be accessed through sliding doors from a
larger starting compartment (30 × 30 cm) at the other
end. A cylindrical food cup (40 mm diameter, 35 mm
high) in each choice compartment could be baited with a
small piece of cereal (30 mg) as a food reward which was
covered with a layer of scented digging medium. The pre-
sence or absence of food reward in a cup was indicated
by either olfactory stimuli (scent of the digging medium)
or tactile stimuli (type of digging medium). We made the
digging mediums with according scent by putting the
digging mediums and perfume together for 12 hours.
Habituation
On the day before testing, each rat was given access to
the test apparatus for adapting for 1 h. Rats were trained
to dig reliably for food reward in the cups. Two
unscented cups were placed in the choice compartments
and baited, with the reward covered with increasing
amounts of home cage bedding. After rats learned to
reliably retrieve the rewards from fully baited cups, they
were transferred to a series of simple discriminations
(SDs) (rubber vs. masking tape; vinegar vs. soy sauce;
styrofoam vs. shredded paper) to a criterion of six con-
secutive correct responses. All rats were trained using
the same stimulus exemplars and in the same order.
These training stimuli were not used again in later test-
ing sessions.
Testing paradigm
Following the training day, rats were tested on a series
of increasingly difficult discriminations (Table 2). Briefly,
a trial was initiated by raising the sliding door to give
the rat access to the two cups, only one of which was
baited. Response latency from opening the sliding door
to the first dig was recorded. Once the rat retrieved the
bait, it was allowed to consume the reward before being
returned to the starting compartment. In the first 4
trials (exploratory trials), the rat was allowed to dig in
both cups, and an error was recorded if the first dug
occurred in the unbaited cup. From trial 5 onwards, the
rat was allowed to dig in one cup only. If the rat started
to dig in the unbaited cup, an error was recorded and
the trial was terminated immediately. Testing at each
stage continued until the rat reached the criterion of six
consecutive correct trials. Trials to criterion and errors
to criterion were recorded for each rat and each stage.
The test box was wiped down with 70% alcohol at the
end of each rat’s session to remove odor cues.
Table 2 shows the order of stages, which were the
same for all rats. In the simple discrimination (SD), the
cups differed along only one of the two dimensions,
either the odor or the digging medium. For the com-
pound discrimination (CD), an irrelevant second dimen-
sion was introduced. The third stage was a reversal of
CD (CDR), in which all exemplars and the relevant
dimension remained unchanged, but the previously
Table 1 Studies examining effects of methylphenidate on attentional set-shifting tests in children with ADHD or
animal models
Citation Dose Time Outcome Subjects
[16] 0.5 mg/kg acute positive effects of ED Children with ADHD
[25] 0.25 mg/kg
0.5 mg/kg
6 days performance were enhanced at a low dose while worsened at a moderate dose of ED Children with ADHD
[26] 0.3 mg/kg
0.6 mg/kg
acute no change Children with ADHD
[27] 35 mg/day no information positive effects of ED Children with ADHD
[28] 0.3 mg/kg
0.6 mg/kg
4 weeks no change Children with ADHD
[6] 1.5 mg/kg 28 days positive effects of ID and ED SHR
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called intradimensional shift (ID), new exemplars of
both dimensions (new odor and new medium) were
used, but the relevant dimension was the same as
before. The fifth stage was a reversal of ID (IDR), as in
CDR. The sixth stage was extradimensional shift (ED),
the most important stage of ASST, in which new exem-
plars of both dimensions were used and the animal had
to shift attention to the previously irrelevant dimension
(from odor/medium to medium/odor). The last stage
was reversal of ED (EDR).
Errors during testing were broken down into 3 sub-
types as has been previously described: perseverative
errors, regressive errors and never-reinforced errors
[30-34]. Briefly, perseverative errors were scored when a
rat continued to use the previously relevant but cur-
rently irrelevant rule. In 6 out of every 12 consecutive
trials the rat was allowed to respond in this way. To
score these types of errors, trials were separated into
consecutive blocks of four trials each in which perse-
verative errors were counted when rats chose unbaited
cup 3 or more trials per block. Once a rat made 2 or
fewer incorrect choice during a block, all subsequent
perseverative errors were counted as regressive errors.
Never-reinforced errors were scored when rats made
incorrect choice using a rule that has never been
rewarded previously. Perseverative errors are considered
as a measure of disengaging from an old rule while
regressive errors and never-reinforced errors are com-
monly considered a measure of engaging in and main-
taining a new rule.
Counterbalancing of task was conducted to minimize
bias in this study: (1) Order of exposure to pairs 1-3
was counterbalanced using a latin square design. For
example, pair 1 was used for the SD/CD/CDR in rat 1
while used for the ID/IDR or ED/EDR in rat 2. (2) Half
of the rats shifted from odor to medium for the ED
(Series 1), and the other half from medium to odor (Ser-
ies 2). (3) The pairs of exemplars were presented
together in a pseudorandom order, with no more than 2
consecutive trials had t h es a m ec o m b i n a t i o no f
exemplars. For example, if O1 vs M1 and O2 vs M2 in
a trial, after no more than two trials, the pattern would
be O1 vs M2 and O2 vs M1. (4) The side of baited cup
presented in the choice compartments was also varied.
Each side was presented for no more than two consecu-
tive trials.
In this study, we took several measures to make the
experiment more precise and reliable: (1) We avoided
using similar odors, which would presumably increase
the difficulty of discrimination and result in increased
numbers of trials to criterion. (2) The scented digging
medium was renewed every 10 trials in order to avoid
scent attenuation. (3) Scent-free baits were chosen to
avoid the rat making choice by the scent of the baits
instead of the stimuli. (4) The degree of hunger was a
potentially confounding factor that may affect the
results. If the rat was too hungry, the latency would be
shorter and the numbers of errors would be increased
compared with those who were relatively full. In this
study we housed the rat individually and used the same
criteria for diet control. (5) During tests, the rat was
drawn back to the waiting compartment repeatedly by
the observer and this may cause stress and fear. To
enhance adaption, all rats were grasped again and again
by their observer for two weeks to reduce stress and
fear toward the observer. (6) Rats showed some purpo-
seless behaviors (e.g. rearing, climbing on the cups,
sniffing the box walls, etc) after they were put into the
test box. The latency was not recorded until animals
stopped those behaviors. (7) We defined a digging
choice as moving the digging medium with the paws or
nose. Contacting or sniffing the cup or medium was not
counted. (8) Sessions terminated when the rat refused to
dig.
Statistical analyses
SPSS 15.0 for Windows was used to perform all statisti-
cal analyses. Data were analyzed by repeated measures
ANOVA with one between-subjects factor (strain/treat-
ment) and one within-subjects factor (stage/error type).
Post hoc analysis was conducted for each stage by
Table 2 Examples of stimulus pairs used in ASST and the progression through the stages of the ASST
Stages SD CD CDR ID IDR ED EDR
Series1 (cup1-cup2) O1▲- O2 O1/M1▲- O2/M2
O1/M2▲-O2/M1
O1/M1- O2/M2▲
O1/M2- O2/M1▲
O3/M3▲- O4/M4
O3/M4▲- O4/M3
O3/M3- O4/M4▲
O3/M4- O4/M3▲
O5/M5▲- O6/M6
O5/M6- O6/M5▲
O5/M5- O6/M6▲
O5/M6▲- O6/M5
Relevant
dimension
Odor Odor Odor Odor Odor Medium Medium
Series 2 (cup1-cup2) M1▲- M2 M1/O1▲- M2/O2
M1/O2▲- M2/O1
M1/O1- M2/O2▲
M1/O2 - M2/O1▲
M3/O3▲- M4/O4
M3/O4▲- M4/O3
M3/O3- M4/O4▲
M3/O4- M4/O3▲
M5/O5▲- M6/O6
M5/O6- M6/O5▲
M5/O5- M6/O6▲
M5/O6▲- M6/O5
Relevant
dimension
Medium Medium Medium Medium Medium Odor Odor
The baited cup is signified by ▲. The exemplars were always presented in pairs and varied. The following pairs of exemplars were used: odor: Pair 1: O1- lemon,
O2- cinnamon, Pair 2: O3- cloves, O4- rose, Pair 3: O5- peppermint, O6- vanilla; Medium: Pair1: M1-sawdust, M2-woodchips, Pair 2: M3-sand, M4-gravel, Pair 3: M5-
confetti, M6- plastic pellets
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test. Violations in sphericity were examined and degrees
of freedom were adjusted using the Greenhouse-Geisser
and Huynh-Feldt epsilon values for large and small vio-
lations respectively. Performance of rats in ID and ED
stages, CD and ID stages was compared with paired t-
tests. Correlation analyses between the stages were per-
formed. Statistical significance was set at p < 0.05. Only
trials to criterion were reported in the following analysis
[15] as trials and errors to criterion were highly corre-
lated, and analysis of either variable produced the same
results.
Results
As shown in Figure 1(A), there was a gradual decrease
in mean latency from SD to EDR shift for all rats. How-
ever, when the rats were faced with new digging med-
ium and new odors in CD, ID and ED shifts, latency
was enhanced compared with in the following reversal
stages (p < 0.001). The SHRs were the quickest respond-
ing rats of the 3 strains, with a mean latency of 14.67 s.
While the WKY rat, the mean latency of whom was
46.39 s, was the slowest. The mean latency of the SD rat
was 26.94 s. The significant main effect of strain [F(2,
21) = 639.636, p < 0.001] was observed in the latency.
Figure 1 (B) showed the mean trials to criterion of each
group at each stage. From the figure we could find sig-
nificant main effect of strain [F(2, 21) = 114.118, p <
0.001] as well as stage [F(6,126) = 21.977, p < 0.001],
and a non-significant strain by stage interaction in trials
[F(12,126) = 1.115, p > 0.05]. Post-hoc tests of multiple
comparisons revealed that the SHR rats needed signifi-
cantly more trials to reach criterion compared with con-
trol strains (p < 0.001) at all stages including simple
discrimination, reversal and shifting stages. There was
no difference in trials between the WKY and SD strains:
n os i g n i f i c a n tm a i ne f f e c to fs t r a i ni nt r i a l s[ F ( 1 , 1 4 )=
2.991, p > 0.05], and no significant strains by stages
interaction in trials [F(6,84) = 0.298, p >0 . 0 5 ] .T h e r e
were no significant correlations between SD and ED on
trials in SHR (r = -0.245, p = 0.558), WKY (r = -0.369, p
= 0.369) and SD (r = 0.448, p = 0.266) rats. The SHR
[paired t(7) = 3.379, p = 0.012], WKY [paired t(7) =
6.426, p = 0.000] and SD rats [paired t(7) = 8.205, p =
0.000] had fewer times of trials to criterion at ID com-
pared to CD. Both the WKY [paired t(7) = 2.676, p =
0.032] and SD rats [paired t(7) = 4.255, p = 0.004] had
fewer times of trials to criterion at ID compared to ED.
No difference of times of trials between the ED and the
ID stages [paired t(7) = 0.456, p = 0.662] were found for
SHR rats. Figure 1 (C) showed the subtypes of errors
made by the 3 rat strains during the whole task. From
the figure we could find significant main effect of strain
[F(2, 21) = 69.839, p < 0.001], error subtype [F(2,42) =
71.194, p < 0.001], and strain by error subtype interac-
tion [F(4,42) = 25.121, p < 0.01]. Post-hoc tests of multi-
ple comparisons revealed that the SHR rats had
significantly more perseverative and regressive errors
compared with control strains (p < 0.01). This indicates
that the SHR has more perseverative responses and is
more impaired in maintaining a new rule. No significant
difference was found on never-reinforced errors between
Figure 1 Strain comparison of the mean latency (A), and the
number of trials to criterion (B) for each of the stage during
the training. (C) Analysis of the subtypes of errors made by
three rats during the whole task. Values are expressed as mean ±
SEM accuracy measured in spontaneous hypertensive rat (SHR),
Wistar-Kyoto (WKY) and Sprague-Dawley (SD) strains. *p < 0.05,**p <
0.01 when compared with SHR rats. #p < 0.01 compared in CD and
ID, ID and ED.
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difference of different types of errors between the WKY
and SD strains (p > 0.05).
Figure 2 (A) showed the mean latency for each of the
stages of the MPH and vehicle treated SHRs. Post-hoc
test revealed significantly longer latency of the MPH-H
group in CD (p <0 . 0 5 ) ,C D R( p <0 . 0 5 ) ,I D( p <0 . 0 5 )
and ED (p < 0.01) compared with the SHR-vehicle
group. Rats in the MPH-L group had significantly longer
latency in ID (p <0 . 0 5 )a n dE D( p < 0.05) than animals
in the SHR-vehicle group. In Figure 2 (B), significant
main effects of treatment [F(2,21) = 52.174, p < 0.001]
and stages in trials [F(6,126) = 14.756, p <0 . 0 0 1 ]a n d
non-significant treatment by stage interaction in trials [F
(12,126) = 0.958, p = 0.496] were observed. Post-hoc
tests revealed significant differences between the SHR-
vehicle and MPH-L groups in their abilities to perform
overall stages (p < 0.01), with the MPH-L group
required significantly less trials to reach criterion com-
pared to the SHR-vehicle group. However, only in CD
(p < 0.05) and ID shift (p < 0.01) stages there were sig-
nificant differences between the SHR-vehicle and the
MPH-H groups. Paired-sample T test of the treated
SHR showed that more trials were needed in ED than in
ID for rats in the MPH-L [t(7) = 3.667, p = 0.035] and
the MPH-H [t(7) = 3.434, p = 0.041] groups. Similarly,
more trials were needed in CD than in ID for rats in
the MPH-L [t(7) = 4.515, p = 0.006] and the MPH-H [t
(7) = 5.716, p = 0.002] groups. In Figure 2 (C), signifi-
cant main effects of treatment [F(2,21) = 78.168, p <
0.01], error subtype [F(2,42) = 221.635, p < 0.01], and
treatment by error subtype interaction [F(4,42) = 23.44,
p < 0.01] were observed. Post-hoc tests revealed signifi-
cant difference in perseverative and regressive errors
between the MPH-L and SHR-vehicle groups (p < 0.01).
Significant difference in perseverative errors was found
between MPH-L and MPH-H groups (p < 0.01).
Discussion
In Experiment 1, we observed poorer performance of
the SHR overall on attentional set-shifting task than the
WKY and SD rats, which suggested that the SHR was
impaired in discrimination learning, reversal learning
and attentional set-shifting. Based on these results, we
believe that impulsivity, perseverative responding and
impairment in maintaining attention could all contribute
to the overall impairment on attentional set-shifting
tasks of the SHRs.
In the ASST, the latency changes can be understood
as either different in speed, accuracy trade off or simply
alterations in locomotor activity [35]. If a rat with long
latencies shows few trials to criterion, it might indicate
a good accuracy trade off strategy. If a rat with short
latencies shows more trials to criterion, then it might
indicate impulsiveness of the rat. In this test, the SHRs
generally had more trials than the WKY and SD rats in
a series of successive discriminations, while the latencies
of the SHR were significantly shorter than the other two
strains in the whole test. This implied that the SHR was
the most impulsive rat of the three strains. The result
was just consistent with what we observed during the
test. When the sliding door was removed, the SHR dug
the cups immediately without any stagger, seldom
Figure 2 Effects of treatment with low-dose methylphenidate
(2.5 mg/kg) and high-dose methylphenidate (5 mg/kg) on
spontaneous hypertensive rat (SHR) strains on the mean
latency (A), the number of trials to criterion (B) and the
analysis of the subtypes of errors (C) during the attentional
set-shifting task. Values are expressed as mean ± SEM *P < 0.05,
**P < 0.01 when compared with vehicle-treated controls. #p < 0.01:
compared in CD and ID, ID and ED,⋆p < 0.01: compared in MPH-H
and MPH-L.
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impulsiveness, the SHR was difficult to have self-control
and make a right decision, thus they had much more
errors and trials than the other two strains. Impulsive
behavior occurred at all stages, so the SHR had impaired
performance at all stages.
Our finding appears consistent with Kantak [6] et al.’s
study which found that the SHRs performed more
poorly than the WKY rats, but contradictory to the
other published study to examine set-shifting in SHRs
b yC h e s sA Ce ta l .[ 1 4 ]w h i c hr e p o r t e dt h a tS H R sw e r e
faster than Wistar rats in shifting to the opposite discri-
mination when there was 1 or 2 days between the initial
discrimination and the shift. We used the WKY and SD
rats and Kantak [6] et al. used WKY rats as control
stains, while Chess AC et al. used the Wistar. The dif-
ference of strains of the control groups may underlie
some of the discrepancies in results and interpretations
in studies [36]. Given the importance of set-shifting for
understanding ADHD, further examination of this issue
may be needed.
Another reason is that the SHR has more persevera-
tive response in shifting. This study found that the
SHRs made significantly more perseverative errors than
the other 2 control strains, which indicates that it is dif-
ficult for the SHRs to disengage from previously relevant
but currently irrelevant strategy during attentional set-
shifting task. It provided an index of poor behavioural
and cognitive flexibility in SHR. Increased perseverative
responses resulted in more series of response at all
stages. What’s more, in this study, the SHRs made sig-
nificantly more regressive errors than the other 2 con-
trol strains, which indicated that they might be impaired
in maintaining attention. This may be the reason of
poorer performance of the SHR overall on attentional
set-shifting task than the WKY and SD rats.
In ASST, It is important to form attentional set firstly
before shifting attentional set. A rat that forms an atten-
tional set should master the ID stage more rapidly
(fewer trials to criterion) than the original discrimina-
tion (CD stage) and poorer performance on ED com-
pared with ID (fewer trials to criterion in ID stage than
in ED stage). In our test, we observed significantly fewer
trials to criterion in ID stage than in CD stage and ED
stage in WKY and SD rats, which suggested that they
could form attentional-set successfully. Meanwhile, it
indicated that the paradigm we used here could serve as
a valuable test paradigm for periadolescent rats. How-
ever, the task performance in ID stage was not improved
in SHRs compared with in ED stage, which suggest that
it was difficult for the SHR to acquire an attentional set
by a series of successive trials. The failure of forming
attentional set of the SHR may be due to their defect of
maintaining attention [37] or dramatic increase in
perseverative responding at the shifting [38]. Garner
[39] presumed that ED was dependent on the repeated
presentations of the relevant dimensions. The SHR may
need more repeated trials to set up an attentional set.
Without the ability to form attentional set, the ED stage
may not be a suitable test to evaluate the ability of set-
shifting. Thus, it was not possible to conclude with cer-
tainty that attentional set-shifting was impaired in the
SHRs compared with the WKY and SD rats. However,
Garner [39] considered the perseverative responding as
one of the reasons relevant to impaired set-shifting. In
this test, the SHR strain was more inclined toward per-
severative responding than other strains. So, the SHR
rats may have a poorer ability of set-shifting compared
to other strains. Previous studies indicate that the
increase in perseverative errors during set-shifting is
related to the dysfunction of medial PFC. Abnormality
in the dorsomedial striatum may underlie the increase
of regressive errors [31,32]. Thus the SHRs may have
impairment of the medial PFC and the dorsomedial
striatum.
In our tests, there was no significant correlation in
performance between SD and ED among all the rats.
The performance in SD could not be the predicted per-
formance in the final ED shift in this test. Our result
was contradictive from the study of Colacicco G [15] et
al., which showed that performances in these two tasks
were significantly correlated in mice. The explanation
might be that our rats were given formal training on
discrimination learning prior to the onset of testing.
In the present study, we found that the performance
of the WKY strain in the ASST was similar to that of
the SD strain at all stages. This finding supported the
continued use of WKY as a control for SHR to investi-
gate the ability of behavioural and cognitive flexibility in
ADHD. Moreover, it suggested that SD rats may be
another useful additional reference strain for SHR.
From the results of Experiment 1, we observed that
like individuals with ADHD, the SHRs may also have
poor performance at attentional set-shifting task com-
pared with the WKY and SD rats. Clear delineation of
the effects of MPH upon attentional set-shifting deficits
in ADHD would enhance understanding of the effects
of drug treatment. In Experiment 2, lower dose (2.5 mg/
kg) and higher dose (5.0 mg/kg) of MPH were adminis-
tered to rats to investigate the dose effect of MPH on
acquiring, maintaining and shifting attentional set of the
SHRs. The results revealed effects of MPH of different
doses on attentional set-shifting. The SHRs who
received lower-dose MPH showed improved perfor-
mance at all stages than the SHR-vehicle group espe-
cially at ED stage. This indicated that lower-dose MPH
could improve PFC-dependent cognitive ability to shift
attentional focus of the SHR. Furthermore, after
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attentional set before set shifting (fewer trials to criter-
ion at ID stage than at CD and ED stages). The reason
maybe that lower-dose MPH could ameliorate impulse,
reduce perseverative response and improve ability of
maintaining attention as rats in the MPH-L group had
increased latency, reduced perseverative and regressive
errors than the SHR- vehicle group. These results were
in consistent with previous clinical reports [40] which
showed that lower dose treatment of MPH on ADHD
could reduce movement and impulsivity and enhance
cognitive function, including sustained attention and
working memory. The performance of higher-dose
MPH treated SHR improved significantly only in CD
stage, ID stage and regressive errors, also formed the
attentional set (fewer trials to criterion in ID stage than
in CD stage and ED stage), but it was noteworthy that
the perseverative errors and other performance of rever-
sal (CDR, IDR, EDR) stages and set-shifting (ED) stage
w e r en o tc h a n g e di nt h i sg r o u pc o m p a r e dt ot h eS H R -
vehicle group. A possible explanation may be that the
higher dose of MPH did not have a significant effect on
perseverative responding and may have even facilitated
perseverative responding to some degree. Arnsten [20]
found that higher doses of MPH induced a perseverative
profile of errors in that the rats continued choosing the
same incorrect arm of the maze in delayed alternation
performance. Similar to rodents, clinicians also consid-
ered that higher doses of MPH could induce persevera-
tive thinking in patients [41]. Thus, the lower dose of
MPH may be more effective than the higher dose in
improving the ability of attentional set-shifting of the
SHR.
Catecholamines in the PFC play a pivotal role in the
cognition-enhancing and therapeutic actions of MPH.
At higher doses, MPH may produce huge and wide-
spread increases in extracellular levels of noradrenaline
(NE) and dopamine (DA) and induce excessive cate-
cholamine receptor stimulation throughout the brain,
which can impair PFC cognitive function. In contrast,
lower doses of MPH, which have behavioral-calming
and cognition-enhancing functions, can exert region-
ally restricted actions, minimal elevated extracellular
catecholamine levels and enhanced catecholamine
receptor actions [20,40] preferentially within the PFC
[19]. Studies showed that lesions of dorsolateral PFC
in primates [42] and of the corresponding medial PFC
in rats and mice [8] induced impairment on the atten-
tion set-shifting, and lesions to the orbitofrontal cortex
(OFC) in primates and rodents impaired reversal learn-
ing [43,44]. By single photon emission computerized
tomography (SPECT), Lee JS [45] found that MPH
could improve ADHD symptoms by normalizing the
OFC activity. Imaging studies have shown that more
efficient dorsolateral PFC activity can be found follow-
ing MPH treatment which is considered to improve
PFC cognitive function [17].T h e r e b y ,w ea s s u m et h a t
lower dose MPH may preferentially increase catechola-
mine neurotransmission within the PFC and enhance
the ability of reversal learning and attentional set-shift-
ing. In contrast, higher dose MPH may induce exces-
sive catecholamine receptor stimulation throughout
the brain and fail to ameliorate the performance on
reversal and shifting set.
Conclusions
In conclusion, the present study revealed deficits in
acquiring, sustaining and shifting attentional set and
reversal learning in the SHRs, a genetic animal model of
ADHD. MPH treatment of ADHD in the SHRs may
ameliorate deficits in attentional set-shifting differently,
and lower doses were more effective than higher doses.
We provided the first evidence of the dose-dependent
effect of MPH on attentional set-shifting performance in
SHRs.
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